Annual revenue:
$1.02B+$186.07M(+22.44%)Summary
- As of today (May 14, 2025), HALO annual revenue is $1.02 billion, with the most recent change of +$186.07 million (+22.44%) on December 31, 2024.
- During the last 3 years, HALO annual revenue has risen by +$572.01 million (+129.03%).
- HALO annual revenue is now at all-time high.
Performance
HALO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$264.86M-$33.15M(-11.12%)Summary
- As of today (May 14, 2025), HALO quarterly revenue is $264.86 million, with the most recent change of -$33.15 million (-11.12%) on March 31, 2025.
- Over the past year, HALO quarterly revenue has increased by +$68.98 million (+35.22%).
- HALO quarterly revenue is now -11.12% below its all-time high of $298.01 million, reached on December 31, 2024.
Performance
HALO Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$1.08B+$68.98M(+6.79%)Summary
- As of today (May 14, 2025), HALO TTM revenue is $1.08 billion, with the most recent change of +$68.98 million (+6.79%) on March 31, 2025.
- Over the past year, HALO TTM revenue has increased by +$221.32 million (+25.65%).
- HALO TTM revenue is now at all-time high.
Performance
HALO TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
HALO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.4% | +35.2% | +25.6% |
| 3 y3 years | +129.0% | +125.8% | +129.9% |
| 5 y5 years | +418.0% | +944.6% | +559.6% |
HALO Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.0% | -11.1% | +125.8% | at high | +129.9% |
| 5 y | 5-year | at high | +418.0% | -11.1% | +944.6% | at high | +559.6% |
| alltime | all time | at high | >+9999.0% | -11.1% | >+9999.0% | at high | >+9999.0% |
HALO Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $264.86M(-11.1%) | $1.08B(+6.8%) |
| Dec 2024 | $1.02B(+22.4%) | $298.01M(+2.7%) | $1.02B(+7.2%) |
| Sep 2024 | - | $290.08M(+25.4%) | $947.36M(+8.5%) |
| Jun 2024 | - | $231.35M(+18.1%) | $873.30M(+1.2%) |
| Mar 2024 | - | $195.88M(-14.8%) | $862.99M(+4.1%) |
| Dec 2023 | $829.25M(+25.6%) | $230.04M(+6.5%) | $829.25M(+6.2%) |
| Sep 2023 | - | $216.03M(-2.3%) | $780.71M(+0.9%) |
| Jun 2023 | - | $221.04M(+36.3%) | $773.65M(+9.7%) |
| Mar 2023 | - | $162.14M(-10.7%) | $704.98M(+6.8%) |
| Dec 2022 | $660.12M(+48.9%) | $181.50M(-13.1%) | $660.12M(+13.7%) |
| Sep 2022 | - | $208.98M(+37.2%) | $580.62M(+19.1%) |
| Jun 2022 | - | $152.37M(+29.9%) | $487.48M(+3.4%) |
| Mar 2022 | - | $117.28M(+15.0%) | $471.57M(+6.4%) |
| Dec 2021 | $443.31M(+65.7%) | $102.00M(-11.9%) | $443.31M(-4.3%) |
| Sep 2021 | - | $115.83M(-15.1%) | $463.01M(+12.2%) |
| Jun 2021 | - | $136.46M(+53.3%) | $412.50M(+24.5%) |
| Mar 2021 | - | $89.02M(-26.9%) | $331.26M(+23.8%) |
| Dec 2020 | $267.59M(+36.5%) | $121.70M(+86.3%) | $267.59M(+34.1%) |
| Sep 2020 | - | $65.32M(+18.3%) | $199.56M(+10.6%) |
| Jun 2020 | - | $55.22M(+117.8%) | $180.47M(+9.8%) |
| Mar 2020 | - | $25.35M(-52.8%) | $164.40M(-16.1%) |
| Dec 2019 | $195.99M(+29.1%) | $53.66M(+16.1%) | $195.99M(-3.2%) |
| Sep 2019 | - | $46.23M(+18.1%) | $202.56M(+11.4%) |
| Jun 2019 | - | $39.15M(-31.3%) | $181.88M(+2.2%) |
| Mar 2019 | - | $56.95M(-5.5%) | $177.94M(+17.2%) |
| Dec 2018 | $151.86M(-52.0%) | $60.23M(+135.7%) | $151.86M(-46.0%) |
| Sep 2018 | - | $25.56M(-27.4%) | $281.19M(-12.0%) |
| Jun 2018 | - | $35.20M(+14.0%) | $319.37M(+0.5%) |
| Mar 2018 | - | $30.87M(-83.7%) | $317.92M(+0.4%) |
| Dec 2017 | $316.61M(+115.8%) | $189.56M(+197.4%) | $316.61M(+90.7%) |
| Sep 2017 | - | $63.73M(+88.8%) | $166.05M(+23.8%) |
| Jun 2017 | - | $33.75M(+14.1%) | $134.17M(+0.3%) |
| Mar 2017 | - | $29.57M(-24.2%) | $133.76M(-8.8%) |
| Dec 2016 | $146.69M(+8.6%) | $39.00M(+22.4%) | $146.69M(-8.3%) |
| Sep 2016 | - | $31.85M(-4.4%) | $159.91M(+7.4%) |
| Jun 2016 | - | $33.34M(-21.6%) | $148.84M(-6.3%) |
| Mar 2016 | - | $42.50M(-18.6%) | $158.89M(+17.6%) |
| Dec 2015 | $135.06M(+79.3%) | $52.23M(+151.3%) | $135.06M(+19.3%) |
| Sep 2015 | - | $20.78M(-52.1%) | $113.21M(+5.8%) |
| Jun 2015 | - | $43.38M(+132.4%) | $107.03M(+30.5%) |
| Mar 2015 | - | $18.67M(-38.6%) | $82.03M(+8.9%) |
| Dec 2014 | $75.33M | $30.38M(+108.0%) | $75.33M(+31.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | $14.61M(-20.6%) | $57.45M(-2.4%) |
| Jun 2014 | - | $18.39M(+53.6%) | $58.86M(+7.2%) |
| Mar 2014 | - | $11.97M(-4.3%) | $54.93M(+0.2%) |
| Dec 2013 | $54.80M(+29.5%) | $12.50M(-22.0%) | $54.80M(-14.5%) |
| Sep 2013 | - | $16.01M(+10.8%) | $64.09M(+20.0%) |
| Jun 2013 | - | $14.45M(+22.1%) | $53.42M(+14.3%) |
| Mar 2013 | - | $11.83M(-45.7%) | $46.72M(+10.4%) |
| Dec 2012 | $42.33M(-24.5%) | $21.79M(+308.6%) | $42.33M(+84.5%) |
| Sep 2012 | - | $5.33M(-31.2%) | $22.94M(-43.4%) |
| Jun 2012 | - | $7.76M(+4.3%) | $40.55M(-27.6%) |
| Mar 2012 | - | $7.44M(+208.6%) | $55.98M(-0.2%) |
| Dec 2011 | $56.09M(+311.7%) | $2.41M(-89.5%) | $56.09M(-2.0%) |
| Sep 2011 | - | $22.94M(-1.1%) | $57.25M(+51.8%) |
| Jun 2011 | - | $23.19M(+207.4%) | $37.70M(+112.7%) |
| Mar 2011 | - | $7.54M(+111.2%) | $17.73M(+30.1%) |
| Dec 2010 | $13.62M(-0.3%) | $3.57M(+5.2%) | $13.62M(-17.4%) |
| Sep 2010 | - | $3.40M(+5.7%) | $16.50M(+2.3%) |
| Jun 2010 | - | $3.21M(-6.6%) | $16.13M(+12.5%) |
| Mar 2010 | - | $3.44M(-46.6%) | $14.34M(+4.9%) |
| Dec 2009 | $13.67M(+56.0%) | $6.44M(+112.7%) | $13.67M(+32.9%) |
| Sep 2009 | - | $3.03M(+112.4%) | $10.29M(+5.8%) |
| Jun 2009 | - | $1.43M(-48.6%) | $9.72M(-0.1%) |
| Mar 2009 | - | $2.77M(-9.5%) | $9.73M(+11.0%) |
| Dec 2008 | $8.76M(+130.7%) | $3.06M(+24.4%) | $8.76M(+24.5%) |
| Sep 2008 | - | $2.46M(+71.7%) | $7.04M(+27.5%) |
| Jun 2008 | - | $1.43M(-20.6%) | $5.52M(+15.1%) |
| Mar 2008 | - | $1.81M(+35.0%) | $4.79M(+26.2%) |
| Dec 2007 | $3.80M(+287.0%) | $1.34M(+41.9%) | $3.80M(+31.6%) |
| Sep 2007 | - | $942.90K(+33.1%) | $2.89M(+25.2%) |
| Jun 2007 | - | $708.50K(-12.6%) | $2.31M(+34.3%) |
| Mar 2007 | - | $810.20K(+90.1%) | $1.72M(+75.1%) |
| Dec 2006 | $981.70K(+671.8%) | $426.30K(+17.6%) | $981.80K(+60.6%) |
| Sep 2006 | - | $362.50K(+202.8%) | $611.40K(+122.7%) |
| Jun 2006 | - | $119.70K(+63.3%) | $274.50K(+36.9%) |
| Mar 2006 | - | $73.30K(+31.1%) | $200.50K(+57.6%) |
| Dec 2005 | $127.20K(+415.0%) | $55.90K(+118.4%) | $127.20K(+78.4%) |
| Sep 2005 | - | $25.60K(-44.0%) | $71.30K(+56.0%) |
| Jun 2005 | - | $45.70K(-185.6%) | $45.70K(>+9900.0%) |
| Dec 2002 | - | -$53.40K(-419.8%) | $0.00(-100.0%) |
| Sep 2002 | - | $16.70K(+114.1%) | $53.40K(+45.5%) |
| Jun 2002 | - | $7800.00(-73.0%) | $36.70K(+27.0%) |
| Mar 2002 | - | $28.90K | $28.90K |
| Dec 2001 | $24.70K | - | - |
FAQ
- What is Halozyme Therapeutics annual revenue?
- What is the all time high annual revenue for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual revenue year-on-year change?
- What is Halozyme Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly revenue year-on-year change?
- What is Halozyme Therapeutics TTM revenue?
- What is the all time high TTM revenue for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM revenue year-on-year change?
What is Halozyme Therapeutics annual revenue?
The current annual revenue of HALO is $1.02B
What is the all time high annual revenue for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual revenue is $1.02B
What is Halozyme Therapeutics annual revenue year-on-year change?
Over the past year, HALO annual revenue has changed by +$186.07M (+22.44%)
What is Halozyme Therapeutics quarterly revenue?
The current quarterly revenue of HALO is $264.86M
What is the all time high quarterly revenue for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly revenue is $298.01M
What is Halozyme Therapeutics quarterly revenue year-on-year change?
Over the past year, HALO quarterly revenue has changed by +$68.98M (+35.22%)
What is Halozyme Therapeutics TTM revenue?
The current TTM revenue of HALO is $1.08B
What is the all time high TTM revenue for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM revenue is $1.08B
What is Halozyme Therapeutics TTM revenue year-on-year change?
Over the past year, HALO TTM revenue has changed by +$221.32M (+25.65%)